Publications by authors named "Bart L Scott"

80Publications

Early Mixed Lymphoid Donor/Host Chimerism is Associated with Improved Transplant Outcome in Patients with Primary or Secondary Myelofibrosis.

Biol Blood Marrow Transplant 2020 Jul 18. Epub 2020 Jul 18.

Fred Hutchinson Cancer Research Center, Seattle, Washington; University of Washington School of Medicine, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2020.07.013DOI Listing
July 2020

Diagnosis of pulmonary hypertension by noninvasive methods in hematopoietic cell transplant patients with myelofibrosis.

Bone Marrow Transplant 2020 Aug 12;55(8):1681-1683. Epub 2019 Dec 12.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-019-0769-9DOI Listing
August 2020

Pre-hematopoietic cell transplant Ruxolitinib in patients with primary and secondary myelofibrosis.

Bone Marrow Transplant 2020 01 8;55(1):70-76. Epub 2019 Apr 8.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-019-0523-3DOI Listing
January 2020

Outcomes of Patients With Therapy-Related MDS After Chemoimmunotherapy for Chronic Lymphocytic Leukemia Compared With Patients With De Novo MDS: A Single-Institution Experience.

Clin Lymphoma Myeloma Leuk 2019 06 11;19(6):390-395. Epub 2019 Mar 11.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2019.03.003DOI Listing
June 2019

Hematopoietic Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria in the Age of Eculizumab.

Biol Blood Marrow Transplant 2019 07 1;25(7):1331-1339. Epub 2019 Feb 1.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.01.033DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6615950PMC
July 2019

Analysis of BMT CTN-0201 and -0901 samples did not reproduce the reported association between recipient REG3A rs7588571 and chronic GVHD.

Bone Marrow Transplant 2019 03 31;54(3):490-493. Epub 2018 Aug 31.

Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41409-018-0331-1
Publisher Site
http://dx.doi.org/10.1038/s41409-018-0331-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395530PMC
March 2019

It's Not All in the Conditioning or the Perils of Early Trial Cessation.

Authors:
Bart L Scott

Biol Blood Marrow Transplant 2018 10 18;24(10):1957-1958. Epub 2018 Aug 18.

Fred Hutchinson Cancer Research Center, University of Washington School of Medicine, Seattle, Washington. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.08.014DOI Listing
October 2018

CC-486 Maintenance after Stem Cell Transplantation in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndromes.

Biol Blood Marrow Transplant 2018 10 20;24(10):2017-2024. Epub 2018 Jun 20.

Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.06.016DOI Listing
October 2018

Allogeneic transplantation for myelofibrosis with adverse risk karyotype: Attack on the clones?

Am J Hematol 2018 05 30;93(5):603-604. Epub 2018 Mar 30.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25078DOI Listing
May 2018

Hematopoietic Cell Transplantation in Myelodysplastic Syndromes after Treatment with Hypomethylating Agents.

Biol Blood Marrow Transplant 2017 Sep 30;23(9):1509-1514. Epub 2017 Jun 30.

Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA; Medical Oncology, University of Washington Medical Center/Seattle Cancer Care Alliance, Seattle, WA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.05.034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481669PMC
September 2017

Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes.

J Clin Oncol 2017 Apr 13;35(11):1154-1161. Epub 2017 Feb 13.

Bart L. Scott and H. Joachim Deeg, Fred Hutchinson Cancer Research Center, Seattle, WA; Marcelo C. Pasquini, Brent R. Logan, Mehdi Hamadani, and Mary M. Horowitz, Medical College of Wisconsin, Milwaukee, WI; Juan Wu and Adam M. Mendizabal, Emmes Corporation, Rockville, MD; Steven M. Devine, Ohio State University Comprehensive Cancer Center, Columbus, OH; David L. Porter, University of Pennsylvania, Philadelphia, PA; Richard T. Maziarz, Oregon Health and Science University, Portland, OR; Erica D. Warlick, University of Minnesota, Minneapolis; Jennifer Le-Rademacher, Mayo Clinic, Rochester, MN; Hugo F. Fernandez, Moffitt Cancer Center, Tampa, FL; Edwin P. Alyea, Dana Farber Cancer Institute, Boston, MA; Asad Bashey, Northside Hospital Cancer Institute, Atlanta, GA; Sergio Giralt, Memorial Sloan Kettering Cancer Center, New York, NY; Nancy L. Geller and Eric Leifer, National Heart, Lung, and Blood Institute, Bethesda, MD; and Mitchell E. Horwitz, Duke University, Durham, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.7091DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455603PMC
April 2017

Mutational analysis in serial marrow samples during azacitidine treatment in patients with post-transplant relapse of acute myeloid leukemia or myelodysplastic syndromes.

Haematologica 2017 06 16;102(6):e216-e218. Epub 2017 Feb 16.

Clinical Research Division, Fred Hutchinson Cancer Research Center, University of Washington and Seattle Cancer Care Alliance, Seattle, WA, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2016.162909DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451346PMC
June 2017

Factors Determining Responses to Azacitidine in Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia with Early Post-Transplantation Relapse: A Prospective Trial.

Biol Blood Marrow Transplant 2017 01 24;23(1):176-179. Epub 2016 Oct 24.

Clinical Research Division, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington; Seattle Cancer Care Alliance, Seattle, Washington. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.10.016DOI Listing
January 2017

Minimal Identifiable Disease and the Role of Conditioning Intensity in Hematopoietic Cell Transplantation for Myelodysplastic Syndrome and Acute Myelogenous Leukemia Evolving from Myelodysplastic Syndrome.

Biol Blood Marrow Transplant 2016 07 6;22(7):1227-1233. Epub 2016 Apr 6.

Fred Hutchinson Cancer Research Center, Seattle, Washington; University of Washington Medical Center/Seattle Cancer Care Alliance, Seattle, Washington. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.03.029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999078PMC
July 2016

The impact of ruxolitinib on thrombosis in patients with polycythemia vera and myelofibrosis: a meta-analysis.

Blood Coagul Fibrinolysis 2016 Sep;27(6):648-52

aDivision of Hematology, University of Washington, Seattle, Washington bDepartment of Biostatistics and Epidemiology, University of Oklahoma, Norman, Oklahoma, USA cDepartment of Medicine, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MBC.0000000000000446DOI Listing
September 2016

Oral Azacitidine (CC-486) for the Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemia.

Oncologist 2015 Dec 13;20(12):1404-12. Epub 2015 Oct 13.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2015-0165DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4679081PMC
December 2015

JAK/STAT Pathway Inhibitors and Neurologic Toxicity: Above All Else Do No Harm?

JAMA Oncol 2015 Aug;1(5):651-2

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle3Division of Hematology, University of Washington, Seattle.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.1591DOI Listing
August 2015

Hematopoietic stem-cell transplantation for advanced systemic mastocytosis.

J Clin Oncol 2014 Oct 25;32(29):3264-74. Epub 2014 Aug 25.

Celalettin Ustun, Ryan Shanley, Gregory Vercellotti, and Daniel Weisdorf, University of Minnesota, Minneapolis; William J. Hogan, Mayo Clinic, Rochester, MN; Andreas Reiter and Sebastian Kreil, Universitätsmedizin Mannheim, Mannheim; Herrad Baurmann, Stiftung Deutsche Klinik für Diagnostik, Wiesbaden; Bernd Gruhn, Jena University Hospital, Jena; Tanja Gromke, University of Essen, Essen; Eva Maria Wagner, Universitätsmedizin Mainz, Mainz; Martin Bornhäuser, Universitätsklinikum Dresden, Dresden; Christoph Schmid, Klinikum Augsburg, Ausburg, Germany; Bart L. Scott and H. Joachim Deeg, University of Washington, Seattle, WA; Ryotaro Nakamura, City of Hope National Medical Center, Duarte; Vinod Pullarkat, University of Southern California, Los Angeles, CA; Gandhi Damaj, Université de Caen, Faculté de Médecine, Caen; Faezeh Legrand, Nice University Hospital, Nice, and Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC); Ibrahim Yakoub-agha, Centre Hospitalier Régionale Universitaire, Lille; Olivier Hermine, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Necker Enfants-Malades, Université Paris 5 Faculté de Médecine et AP-HP Necker-Enfants Malades, and Centre de Référence des Mastocytoses, Paris, France; Miguel-Angel Perales and Esperanza B. Papadopoulos, Memorial Sloan-Kettering Cancer Center; Tsiporah Shore, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY; Robert Stuart, Medical University of South Carolina, Charleston, SC; Michael Doubek, Masaryk University, Brno, Czech Republic; Jack W. Hsu, University of Florida, Gainesville, FL; Eleni Tholouli, Manchester Royal Infirmary, Manchester, United Kingdom; Lucy A. Godley, University of Chicago, Chicago, IL; Livio Pagano, Università Cattolica del Sacro Cuore, Milan; Maria Teresa Van Lint, Istituto Di Ricovero e Cura a Carattere Scientifico San Martino-IST, Genova, Italy; Andrew Gilman, Levine Children's Hospital, Charlotte, NC; Tor Shwayder, Henry F

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.55.2018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876356PMC
October 2014

Transplantation for myelodysplastic syndromes 2013.

Curr Opin Hematol 2013 Nov;20(6):494-500

Clinical Research Division, Fred Hutchinson Cancer Research Center, and the University of Washington School of Medicine, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/co-hematology/2013/11000/Transp
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/MOH.0b013e328364f547DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933200PMC
November 2013

Emerging importance of mutational analysis in myelodysplastic syndrome and acute myelogenous leukemia.

Biol Blood Marrow Transplant 2013 Jan;19(1 Suppl):S33-7

Fred Hutchinson Cancer Research Center, Seattle, Washington; University of Washington, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2012.11.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897298PMC
January 2013

Last marrow standing: bone marrow transplantation for acquired bone marrow failure conditions.

Curr Hematol Malig Rep 2012 Dec;7(4):292-9

Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine, 1100 Fairview Avenue N, D1-100, Seattle, WA, 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-012-0138-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3640337PMC
December 2012

Pretransplantation therapy with azacitidine vs induction chemotherapy and posttransplantation outcome in patients with MDS.

Biol Blood Marrow Transplant 2012 Aug 16;18(8):1211-8. Epub 2012 Jan 16.

Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N., Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2012.01.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376402PMC
August 2012

Myelodysplastic syndromes: emerging therapies, survival, and alternative outcomes.

Authors:
Bart L Scott

Manag Care 2009 Nov;18(11 Suppl 9):4-12; discussion 13-4

University of Washington Medical Center, Seattle, USA.

View Article

Download full-text PDF

Source
November 2009

Prolonged responses in patients with MDS and CMML treated with azacitidine and etanercept.

Br J Haematol 2010 Mar 7;148(6):944-7. Epub 2010 Jan 7.

Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N., Seattle, WA 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2009.08061.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864317PMC
March 2010

Myelodysplastic syndromes.

Annu Rev Med 2010 ;61:345-58

Fred Hutchinson Cancer Research Center and University of Washington School of Medicine, Seattle, Washington 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1146/annurev.med.051308.132852DOI Listing
May 2010

Clinical roundtable monograph. Combination therapies for MDS.

Authors:
Bart L Scott

Clin Adv Hematol Oncol 2009 Jul;7(7):S13-5

University of Washington Medical Center, Seattle, WA, USA.

View Article

Download full-text PDF

Source
July 2009

Management of myelodysplastic syndromes: 2008 update.

Oncology (Williston Park) 2008 Nov;22(12):1344-52

University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2647329PMC
November 2008

Marrow fibrosis as a risk factor for posttransplantation outcome in patients with advanced myelodysplastic syndrome or acute myeloid leukemia with multilineage dysplasia.

Biol Blood Marrow Transplant 2007 Mar;13(3):345-54

Department of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2006.10.030DOI Listing
March 2007

Outcomes with myeloid malignancies.

Hematology Am Soc Hematol Educ Program 2006 :381-9

Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2006.1.381DOI Listing
June 2007

Hemopoietic cell transplantation for the myelodysplastic syndromes.

Arch Immunol Ther Exp (Warsz) 2005 Jul-Aug;53(4):297-307

Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.

View Article

Download full-text PDF

Source
December 2005

Pretransplantation induction chemotherapy and posttransplantation relapse in patients with advanced myelodysplastic syndrome.

Biol Blood Marrow Transplant 2005 Jan;11(1):65-73

Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2004.10.001DOI Listing
January 2005

Cases from the Osler Medical Service at Johns Hopkins University.

Authors:
Bart L Scott

Am J Med 2002 Apr;112(5):417-8

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0002-9343(02)01092-6DOI Listing
April 2002